Stocks
Intellia Therapeutics (NTLA) Net margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -810.5% | -909.8% | -1 327% | -896.8% | -609.9% | -597.0% | ||
| Changes by years, y/y, % | -579pp | -99pp | -417pp | +430pp | +287pp | +21.4% | |||
Intellia Therapeutics. Net margin, %
Intellia Therapeutics. Net margin, changes, pp
Intellia Therapeutics (NTLA) Net margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Net margin, % | ? | -687.6% | -710.8% | -735.2% | -416.2% | -639.5% | -597.0% | |
| Changes by years, y/y, % | -316pp | +1 402pp | +754pp | +585pp | +48pp | |||
| Changes by quarters, q/q, % | +314pp | -23pp | -24pp | +319pp | -223pp | |||
